CSRA’s High Performance Computing Expertise (HPC) Will Aid NIH in Developing New Advancements in Medicine and Cancer Research
FALLS CHURCH, VA – CSRA Inc. (NYSE:CSRA) announced today it has installed a second increment to the Biowulf supercomputing cluster at the National Institutes of Health (NIH) Center for Information Technology. Biowulf is designed to process a large number of simultaneous computations that are typical in genomics, image processing, statistical analysis, and other biomedical research areas.
“We are proud to report the next stage of supercomputing power for Biowulf at NIH,” said Vice President Kamal Narang, head of CSRA’s Federal Health Group. “CSRA’s world-renowned HPC experts partnered with NIH to make this advancement possible. Entering this new stage, NIH researchers have expanded computing power to discover new cures and save lives.”
The second stage of computing power announced today will enable NIH researchers to make important advances in biomedical fields. This field of research is deeply dependent on computation, such as whole-genome analysis of bacteria, simulation of pandemic spread, and analysis of human brain MRIs. Results from these analyses may enable new treatments for diseases including cancer, diabetes, heart conditions, infectious disease, and mental health.
This increment to Biowulf, which ranked #139 on the June 2017 TOP500 list of supercomputing sites, features compute nodes from Hewlett Packard Enterprise, with Intel processor and NVIDIA GPU technology; large scale storage from DataDirect Networks; Infiniband interconnect components from Mellanox Technologies; and Ethernet switches from Brocade Communication Systems.
The scope and performance of this second increment to Biowulf includes:
- 1,104 compute nodes (1.2 Petaflops or 1.2 thousand trillion operations per second) and
- 72 GPU nodes added to the existing 2,372 node cluster (1.6 Petaflop)
- An additional 4.8 Petabytes (4.8 thousand trillion bytes of data) of storage
As the prime contractor, CSRA procured all of the components and managed the integration and installation of the equipment into the Biowulf system while collaborating with several industry partners. CSRA is also helping support the ongoing operation of the Biowulf cluster.
CSRA is a leader in HPC services, helping a wide variety of government customers achieve important mission objectives. Recently, the company was awarded a $51 million contract to support the Environmental Protection Agency’s (EPA) HPC systems. In addition to NIH and the EPA, CSRA supports supercomputers used by NASA, NOAA, the CDC, and the Department of Defense. This technology is used for applications ranging from aerospace system design, climate and weather modeling, astrophysics, ecosystems modeling, to health and medical research.
About CSRA Inc.
CSRA (NYSE: CSRA) solves our nation’s hardest mission problems as a bridge from mission and enterprise IT to Next Gen, from government to technology partners, and from agency to agency. CSRA is tomorrow’s thinking, today. For our customers, our partners, and ultimately, all the people our mission touches, CSRA is realizing the promise of technology to change the world through next-generation thinking and meaningful results. CSRA is driving towards achieving sustainable, industry-leading organic growth across federal and state/local markets through customer intimacy, rapid innovation and outcome-based experience. CSRA has over 18,000 employees and is headquartered in Falls Church, Virginia. To learn more about CSRA, visit www.csra.com. Think Next. Now.
All statements in this press release and in all future press releases that do not directly and exclusively relate to historical facts constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements represent CSRA's intentions, plans, expectations and beliefs, including statements about the effects of the program on our business and our ability to enhance mission capabilities of our customers. The forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside the control of CSRA. These factors could cause actual results to differ materially from forward-looking statements. For a written description of these factors, see the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in CSRA's most recent Annual Report on Form 10-K and any updating information in subsequent SEC filings. CSRA disclaims any intention or obligation to update these forward-looking statements whether as a result of subsequent event or otherwise.